EASL Quiz
Take the new one now!
Look at this follow up question of the 40-year-old male patient case seen few weeks ago and check your Guidelines knowledge!
EASL Studio
Wednesday 8 May, 18:00 CET
Do we care enough about the importance of DILI/DHILI ?
EASL Journal Club
Now on demand!
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab
EASL Molecular Tumour Board
On demand!
Catch up with the presentation and discussion of this clinical case of cholangiocarcinoma.
Steatotic liver disease – the missing piece in the NCD puzzle
Now on-demand!
Discover the priorities and recommendations for the upcoming WHA77 agenda established by EASL, representatives from the WHO, patient advocate, NCD Alliance, and more !
You may also be interested in
Our Sponsors